|
1
|
Fidelity Investments
Boston,
Massachusetts
|
$872M
|
+$1.74M
|
+24,615
|
+0.2%
|
|
|
2
|
Wellington Management Group
Boston,
Massachusetts
|
$813M
|
+$1.81M
|
+25,696
|
+0.2%
|
|
|
3
|
Vanguard Group
Malvern,
Pennsylvania
|
$367M
|
+$2.29M
|
+32,440
|
+0.6%
|
|
|
4
|
Dodge & Cox
San Francisco,
California
|
$358M
|
+$195M
|
+2,759,399
|
+110%
|
|
|
5
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$273M
|
+$2.06M
|
+29,266
|
+0.7%
|
|
|
6
|
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
$228M
|
-$1.55M
|
-21,927
|
-0.6%
|
|
|
7
|
State Street
Boston,
Massachusetts
|
$158M
|
+$9.71M
|
+137,672
|
+6%
|
|
|
8
|
BlackRock Fund Advisors
San Francisco,
California
|
$131M
|
+$3.98M
|
+56,455
|
+3%
|
|
|
9
|
BlackRock Institutional Trust
San Francisco,
California
|
$129M
|
-$1.69M
|
-23,987
|
-1%
|
|
|
10
|
|
$103M
|
-$10.2M
|
-144,120
|
-9%
|
|
|
11
|
Gilder Gagnon Howe & Co
New York
|
$92.3M
|
-$2.28M
|
-32,291
|
-2%
|
|
|
12
|
Blue Ridge Capital
New York
|
$89.5M
|
–
|
–
|
–
|
|
|
13
|
Slate Path Capital
New York
|
$83M
|
+$6.35M
|
+90,000
|
+8%
|
|
|
14
|
BB Biotech
Schaffhausen,
Switzerland
|
$80.7M
|
–
|
–
|
–
|
|
|
15
|
Bridger Management
New York
|
$66.6M
|
+$20.9M
|
+296,031
|
+43%
|
|
|
16
|
|
$64.3M
|
+$8.17M
|
+115,737
|
+14%
|
|
|
17
|
|
$63.9M
|
+$17.6M
|
+249,691
|
+36%
|
|
|
18
|
|
$57M
|
-$2.45M
|
-34,692
|
-4%
|
|
|
19
|
Jennison Associates
New York
|
$53M
|
-$13.7M
|
-193,769
|
-20%
|
|
|
20
|
Franklin Resources
San Mateo,
California
|
$48.4M
|
+$8.61M
|
+122,000
|
+21%
|
|
|
21
|
12 West Capital Management
New York
|
$47.4M
|
–
|
–
|
–
|
|
|
22
|
|
$40.7M
|
-$7.76M
|
-110,000
|
-15%
|
|
|
23
|
Capital World Investors
Los Angeles,
California
|
$38.9M
|
–
|
–
|
–
|
|
|
24
|
|
$35.5M
|
+$6.14M
|
+87,008
|
+19%
|
|
|
25
|
Geode Capital Management
Boston,
Massachusetts
|
$35.2M
|
+$1.43M
|
+20,289
|
+4%
|
|
